Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. is a clinical-stage biopharmaceutical company dedicated to the research, development, and eventual commercialization of innovative cancer treatments. Its primary focus is on Alpha DaRT (diffusing alpha-emitters radiation therapy), a novel approach designed to effectively treat solid tumors. The company's initial commercialization efforts are concentrated in Israel and the United States. Currently, Alpha DaRT is undergoing clinical trials for various malignancies, including skin, oral, pancreatic, and breast cancers. Beyond this, preclinical studies are investigating its potential efficacy against hepatic cell carcinoma, lung, and prostate cancers. Established in 2015, Alpha Tau Medical maintains its headquarters in Jerusalem, Israel.